baber/WOPTO huggingface dataset:
Patent NZ-505101-A (NZ)
Title: Double spring mattress and manufacturing process with superposed layers of springs enclosed in covers
Inventor: STJERNA NILSERIC
IPC: A47C27/06
Filed: 1998-12-10
Abstract: Disclosed is a spring mattress having two superposed layers of springs, which are enclosed in covers (4), and a method of manufacturing a mattress of this kind. Characterising features are that the springs of the upper layer are positioned essentially straight above the corresponding springs in the lower layer, and that the covers are joined together in such a manner that the springs in the lower layer are affected at least to some extent by the spring above, in the upper layer, independently of neighbouring springs.
Patent NZ-512913-A (NZ)
Title: Electrolytic cell arrangement for production of aluminium
Inventor: GAILLARD JEAN-MARIE
IPC: C25C3/16
Filed: 2000-02-01
Abstract: An   electrolytic  cell  arrangement  (1),   disposed transversely,   for   producing  aluminium   by   fused-salt electrolysis  in  accordance with the Hall-Heroult  process, comprising  at  least  a  first row of  electrolytic  cells, forming  a  first electric circuit, and at  least  a  second electric  circuit located at a specific mean  distance  from the  first  row. The invention is characterised in  that  at least  one  conductor (7), said to be axial, passes  beneath each  upstream  cell, in the central zone, and  at  least  a conductor  (8),  said  to be lateral,  passes  beneath  each upstream  cell, in the inner lateral zone, and at least  one conductor  (11A, 11B), said to be bypassing,  bypasses  each upstream  cell,  and  said  or  each  lateral  conductor  is connected  to  a first set of said cathode bar ends  located on  the upstream side so as to transmit to said risers  (6A, 6B,  6D,  6E) a first part (I1) of the current (Im), ranging between  20 and 20 % of said current (Im), and said or  each axial conductor is connected to a second set of cathode  bar ends  located on the upstream side so as to transmit to said risers  (6A, 6B. 6D, 6E) a second part (I2) of said  current (Im),  ranging between 10 and 20 % of said current  Im,  and said  or  each bypassing conductor is connected to  a  third set  of cathode bar ends located on the upstream side so  as to   transmit  a  third  part  (I3)  of  the  current  (Im), corresponding to the remainder of the current Im,  and  said risers  are  connected to said cathode bar ends  located  on the  downstream side of the corresponding upstream cell,  to the  conductors passing beneath said cell, and  to  said  or each  bypassing conductor of said cell, such that a fraction (Mc)  of said current (Io) less than 15 % is transmitted  to the risers located in the central zone of the row.
Patent NZ-513232-A (NZ)
Title: Object recognition and tracking system
Inventor: COHEN PETER GEOFFREY
IPC: G01S7/40
Filed: 2000-02-01
Abstract: An object recognition and tracking system having detector arrays (60, 70), each detector array (60, 70) including a first type of detector (95) and a second type of detector (96). The first type of detector (95) detects the presence of an object such as by changing contrast boundaries and hence objects (91, 92) that move in a detector space (90) and the second type of detector (96) focuses in on the defined object (91, 92) and to recognise, identify or record it. The detectors (95, 96) may be video, radar, microwave, radio frequency, infrared, millimetre wave, or transponder interrogators or a combination of these. Tracking of objects (91, 92) between adjoining detector spaces (90, 90) may also be done.
Patent NZ-522326-A (NZ)
Title: Adenosine A2A receptor antagonists
Inventor: NEUSTADT BERNARD R
IPC: A61K31/505
Filed: 2001-05-24
Abstract: Compounds having the structural formula (I) or a pharmaceutically acceptable salt thereof are disclosed. Their use in the treatment of Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them; also disclosed are a processes for preparing intermediates useful for preparing compounds of formula (I).
Patent NZ-527296-A (NZ)
Title: Atmospheric density-dependent power adjustment for wind turbines
Inventor: WOBBEN ALOYS
IPC: F03D11/00
Filed: 2002-02-21
Abstract: A method of controlling a wind power installation is disclosed. The wind power installation includes an electrical generator (12) that uses inputted and/or measured air density data at the location of the wind power installation and/or air density data corresponding to the air density which prevails at the site of the wind power installation, where the generator (12) of the wind power installation is controlled by a control apparatus (20) which processes the air density data, and power data of the generator (12). In particular the exciter power supplied to the generator (12) is set in dependence on the air density. A wind power installation is also disclosed which includes an electrical generator (12) and a control device (20) for operational management of the generator (12) of the wind power installation. There is provided means (16) for detecting and/or setting air density data, where the detected and/or set air density data is processed in the control apparatus (20). The power data with the power to be delivered by the generator (12) of the wind power installation, in particular the exciter power supplied to the generator (12) can be set in consideration of the detected and/or set data in respect of air density.
Patent NZ-528703-A (NZ)
Title: Novel PRO337 polypeptides and nucleic acids encoding a neurotrimin polypeptide
Inventor: WOOD WILLIAM I
IPC: A61K39/395
Filed: 1999-03-08
Abstract: An isolated nucleic acid having at least 91% sequence identity to a nucleotide sequence that encodes a polypeptide designated PRO337 comprising the amino acid sequence SEQ ID NO:523 is described. Preferably the nucleic acid comprises the sequence of SEQ ID NO:522 or is that deposited under accession number ATCC 209487. Vectors, isolated host cells, processes for preparing the polypeptide and antibodies are also described. (62) Divided out of 507435
Patent NZ-531108-A (NZ)
Title: Baffle for assisting the upstream passage of aquatic fauna
Inventor: DAVIES PETER E
IPC: F15D1/00
Filed: 2004-02-11
Abstract: A baffle provided to assist the upstream passage of aquatic fauna along the water flow through a channel includes an upstream face having a leading end and a following end connected by a curved profile. The lowest point of the profile is located towards the leading end and the highest point of the profile is located towards the following end. The baffle also includes a downstream face having a substantially vertical profile wherein, the baffle is placed in the channel with the upstream face positioned facing the dominant direction of the water flow to create regions of slow water flow inside the channel.
Patent NZ-536939-A (NZ)
Title: Compositions and method for enhanced mucosal delivery of interferon beta
Inventor: QUAY STEVEN C
IPC: A61K38/21
Filed: 2003-06-18
Abstract: A stable pharmaceutical composition comprises an interferon-beta compound formulated for mucosal delivery in combination with one or more mucosal delivery-enhancing agents. The composition following administration yields (i) a peak concentration (Cmax) of the interferon-beta compound(s) in a CNS tissue or fluid, or in a blood plasma of the subject that is 15% or greater as compared to a peak concentration of said interferon-beta compound in CNS or blood plasma following intramuscular injection of an equivalent concentration or dose of the interferon-beta compound to the subject; (ii) an area under concentration curve (AUC) of the interferon-beta compound in a central nervous system (CNS) tissue or fluid, or in a blood plasma of the subject that is 25% or greater compared to an AUC of interferon-beta in CNS or blood plasma following intramuscular injection of an equivalent concentration or dose of the interferon-beta compound; or (iii) a time to maximal concentration(tmax) of the interferon-beta in a central nervous system (CNS) tissue or fluid or in a blood plasma of the subject between about 0.1 to 1.0 hours. The composition is useful for the treatment of autoimmune and viral diseases.
Patent NZ-537298-A (NZ)
Title: Process of allocating seats to customers in a computer reservation system
Inventor: FAVOREL OLIVIER
IPC: G06Q10/00
Filed: 2003-06-13
Abstract: A process of allocating seats to customers usable with a computerized reservation system is disclosed, where this process is particularly useful for the reservation of aircraft seats. The process includes the following allocation steps: (a) assigning, in a database, to each customer, data relating to criteria of placement, (b) determination of a value of satisfaction of the customer for a seat as a function of its adequacy with respect to the placement criteria, (c) assigning, in a database, to each customer, a level of priority, (d) allocating, to each customer, by decreasing order of level of priority, the available seat having the maximum satisfaction value.
Patent NZ-543118-A (NZ)
Title: Edible products containing a plant sterol ester, and having a reduced content of sugar or other sweetening agents that are normally added for masking bitterness, sourness and/or astringent taste
Inventor: HONKANEN ANNIINA
IPC: A23L5/20
Filed: 2004-04-22
Abstract: Disclosed is an edible product with masked bitter, sour and/or astringent taste, said product comprising a sweetening agent and from 0.2 to 25% by weight plant sterol ester, wherein the amount of sweetening agent is reduced as compared to a regular product.
Patent NZ-544871-A (NZ)
Title: Continuous transfer type freezer
Inventor: ARAI TAKAHIRO
Filed: 2004-10-29
Abstract: This discloses a continuous transfer type freezer comprising a housing having an entrance opening and an exit opening, a conveyor belt 2 for transferring articles w to be cooled from the entrance opening to the exit opening through the housing, a chilled air circulating means consisting of a cooler and a blower, and slit nozzles for spouting chilled air k against the articles to be cooled, where a number of upper slit nozzles 5a and lower slit nozzles 6a are placed above and under the conveyor belt along the direction of transfer a of the belt with the slit of each nozzle perpendicular to the belt transfer direction a, and exhaust passages 12 are formed perpendicular to the belt transfer direction a between each of the slit nozzles 5a, 6a to guide the chilled air spouted from the slit nozzles 5a, 6a to both lateral end sides of the conveyor belt.
Patent NZ-549446-A (NZ)
Title: Looped system fuel-fired fluid heating/storage device
Inventor: MISSOUM OZZIE
Filed: 2006-08-25
Abstract: A fuel fired commercial water heater 10 has a three pass condensing heat exchanger 12 disposed within the water tank 16. The inlet of vertical flue 22 is connected to the outlet 20 of a fuel burner and the lower end of the flue is connected to a central collector plenum 24 which is circumscribed by an outer plenum 26 to which the exhaust pipe 30 is coupled. A set of interconnected vertical tube structures 28a, 28b are disposed above the plenum structures and communicate via inlets to the central plenum and via outlets to the outer plenum. Combustion gases from the fuel burner flow 18 sequentially down through the flue 22 into the central plenum 24, up through the tube structures 28a, down through the tube structures 28b into the outer plenum 26, and then outwardly through the exhaust pipe 30.
Patent NZ-551169-A (NZ)
Title: Method of detecting and predicting bronchodilatory response to beta agonist
Inventor: KUKRETI RITUSHREE
IPC: C12Q1/68
Filed: 2004-04-29
Abstract: Provided is a method of detecting single nucleotide polymorphism (SNP) in beta2AR gene associated with pharmacogenetic response in a human subject suffering from asthma, wherein said method is carried out on a blood sample of a subject who has been identified and categorized as a phenotypically good responder or poor responder to a pharmaco-logically active dose of a fast acting beta2 agonist, said method comprising the steps of: (a) isolating genomic DNA from the blood sample of the subject suffering from asthma; (b) amplifying the genomic DNA obtained in step (a) using specified PCR primers (c) sequencing the amplified PCR product obtained in step (b) and identifying the SNP of the sequenced PCR product to detect the specific beta2AR genotypes; (d) screening for polymorphism at position 46 to detect the specific SNP in beta2AR gene using specified snapshot primers, until the penultimate position of the SNP identified in step (c), and; (e) validating the subject for presence of SNP at nucleotide position 46 in beta2AR gene using specified allele specific oligonucleotides. Further provided are corresponding pharmaco-genetic marker polynucleotides comprising at least 20 base pairs encompassing the A/G polymorphism at position 46.
Patent NZ-562914-A (NZ)
Title: Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods
Inventor: DEVASTHALE PRATIK
IPC: A61K31/407
Filed: 2006-05-11
Abstract: Disclosed is a compound according to formula (I) according to claim 1. Particularly preferred embodiments include a dichlorophenyl moiety at position Y. Further disclosed are pharmaceutical compositions containing said compounds and uses thereof in the manufacture of a medicament for the treatment of diabetes and other related diseases.
Patent NZ-565109-A (NZ)
Title: Single stranded oligonucleotides having substantially no secondary structure wherein two or more internal nucleotides are labelled with a fluorophore
Inventor: MCDOWELL DAVID GORDON
IPC: C07H19/00
Filed: 2006-07-20
Abstract: Disclosed is a single stranded oligonucleotide which does not have a sequence containing parts made of four or more consecutive nucleotide residues which are the inverse complement of each other which allow for intramolecular base pairing and which is formed of nucleotide residues, wherein the bases of two or more internal nucleotide residues are labelled with a flurophore without an associated quencher, and wherein at least two of the nucleotide residues labelled with a flurophore are separated by at least two unlabelled residues.
Patent NZ-565396-A (NZ)
Title: 7-substituted aza-indazoles, compositions containing same, production method and use thereof
Inventor: SOUAILLE CATHERINE
IPC: A61K31/437
Filed: 2006-08-01
Abstract: Disclosed is a pyridopyrazole derivative of formula (I), where X is N or NO and the other substituents are as defined in the specification. Also disclosed is the use of the compound for inhibitng a reaction catalysed by one or more kinases, such as FAK, KDR, and Tie2, and for the treatment of diseases such as cancer, rheumatoid arthritis, osteoarthritis, inflammatory diseases of the intestine, eye pathologies chronic inflammation, and psoriasis. Also disclosed are intermediates useful in preparing the above compound.
Patent NZ-569966-A (NZ)
Title: Appliance & power supply therefor
Inventor: BUTLER RICHARD
IPC: H02M7/02
Filed: 2008-07-18
Abstract: A power supply has an input for coupling to an AC voltage, a rectifier coupled to the input for receiving and rectifying an AC voltage, a voltage dropping resistor coupled in the circuit to provide a voltage drop between the input and an output of the power supply, and a smoothing circuit coupled to receive the rectified AC voltage and provide an output voltage. The smoothing circuit comprises at least a first and a second capacitor to stabilise the output voltage, and a switching network to switch the capacitors between a first configuration with a first effective voltage rating, and a second configuration with a second effective voltage rating.
Patent NZ-572394-A (NZ)
Title: Carton with vent openings and a tear line to open the carton
Inventor: COLTRI-JOHNSON ANDREA
IPC: B65D5/08
Filed: 2007-05-03
Abstract: A blank (10) and carton is disclosed. The blank and carton provides at least one aperture (66, 68, 70, 72) in at least one end flap (64, 74) to allow exchange of air between the inside of a carton formed from the blank and the outside. The blank and/or carton can include more than one aperture in an end flap, in adjacent end flaps, in end flaps at both ends of the blank or carton, in end flaps at either the exiting end of the carton, the non-exiting end, or both. A method of exchanging air is also described.
Patent NZ-577491-A (NZ)
Title: 2-heteroaryl-3-hydroxy-4-oxo-pyrido[1,2-a]pyrimidines and uses thereof
Inventor: JONES ERIC DALE
IPC: A61K31/4375
Filed: 2007-12-21
Abstract: Disclosed are compounds of general formula (I) and particularly those which are 3-hydroxy-4-oxo-pyrido[1,2-a]pyrimidine derivatives which are useful for the treatment of viral infections, wherein: A is a monocyclic or bicyclic aromatic or heteroaromatic moiety fused to the nitrogen containing ring; X and Y are independently selected from the group consisting of O and S; B and C are absent; R2 is an optionally substituted heteroaryl or heterocyclyl group; and wherein the other substituents are as defined herein.
Patent NZ-587500-A (NZ)
Title: A method for presenting an updated status overview of persons staying in one or more specific geographical locations abroad
Inventor: Onsagers AS
IPC: H04W4/90
Filed: 2009-02-19
Abstract: A method for presenting an updated status overview of persons staying in one or more specific geographical locations abroad is disclosed. Where it is desirable to send a message to the person or persons concerned, each person is associated with, and identified by, a Mobile Subscriber Integrated Services Digital Network (MSISDN) number in a mobile network. The steps of the method are executed in a server which is connected to the mobile network. The server is in communication with one or more clients with a user interface, and a database comprising updated location information for MSISDN numbers associated with the persons staying in different locations abroad. The steps of the method comprise: (a) receiving a query from the client comprising information about a relevant geographical location or locations where a message transmission is desirable; (b) collecting relevant information from the database based on the queried location, where the information comprises relevant personal details for persons associated with MSISDN numbers who are currently located in the queried location, and sending this information to the client for presentation on the user interface; (c) receiving information from the client about the message to be sent to MSISDN numbers located in a relevant location or locations; (d) sending the message to persons associated with relevant MSISDN numbers; (e) receiving and processing any response messages from persons who receive the message, updating status information of the persons in the database based on the response messages, and categorizing such response messages into categories according to the type of response given and/or technical status/fault messages; (f) sending additional information as a result of an undesired event to persons who are still in the area in question to follow up these persons; and (g) sending the updated status information to the client for presentation of status of the persons.
Patent NZ-593495-A (NZ)
Title: Disc for industrial plants
Inventor: PINCHES DAVID KENNETH
IPC: F26B17/00
Filed: 2011-06-16
Abstract: 593495 A disc comprises two annular plates 16 connected to one another at an angle around corresponding outer peripheral edges 24 such that corresponding inner peripheral edges 22 of the plates 16 are spaced apart from one another. Each plate 16 comprises one or more integral ribs 20 extending substantially radially between its inner edge 22 and outer edge 24. The integral ribs 20 are formed from folds in the annular plate 16. The disc is for use in a dryer, and due to its simpler construction is easier to replace.
Patent NZ-593684-A (NZ)
Title: Novel vanilloid receptor ligands and their use for producing medicaments
Inventor: FRANK ROBERT
IPC: A61K31/10
Filed: 2006-10-19
Abstract: Disclosed are (4-(alkylsulfonamido)phenyl)-N-(alkylphenyl)-alkylamide derivatives of the general formula A, wherein at least one of T, U V and W are Nitrogen which are optionally substituted; and wherein the remaining substituents are as defined herein. Further disclosed is a medicament which contains a compound as defined above for the treatment and/or prevention of one or more diseases selected from the group consisting of depression; neuropathy; nerve injury; neurodegenerative diseases; cognitive dysfunction; epilepsy; pain; psoriasis; vitiligo; herpes simplex; inflammation; diarrhoea; pruritus; osteoporosis; arthritis; osteoarthritis; rheumatic diseases; asthma, bronchitis and pulmonary inflammation.
Patent NZ-595085-A (NZ)
Title: Apparatus for forming the leg openings of nappies on a continuous web, comprising a cutter roller to die cut a predetermined shape in the web
Inventor: YAMAMOTO HIROKI
IPC: A61F13/15
Filed: 2010-03-02
Abstract: 595085 A nappy or diaper leg-surrounding opening forming apparatus (100) is disclosed. The apparatus comprises a cutter roller (110) having an outer circumferential surface provided with blades (112), an anvil roller (120) facing the cutter roller, and a controller unit which controls the circumferential speed of the rollers. The cutter roller rotates at a fixed speed to cut leg-surrounding openings in a continuous web. The controller can control the size of the openings cut by adjusting the circumferential speed of the roller. The apparatus can cut a first size and a second size leg-surrounding opening, the latter is narrower in width due to faster rotation of the cutter roller.
Patent NZ-595848-A (NZ)
Title: Method for preparing a site-specific physiologically active polypeptide conjugate
Inventor: SONG DAE HAE
IPC: C07K1/14
Filed: 2010-03-18
Abstract: 595848 Disclosed is a method for preparing a site-specific physiologically active polypeptide conjugate, comprising the steps of: i) determining a kind and amount of an alcohol and a pH range where desired positional isomers exist more than undesired positional isomers by identifying a ratio of the desired and undesired positional isomers of a conjugate of a physiologically active polypeptide and a non-peptidyl polymer, depending on the change of the kind and amount of an alcohol (such as ethanol or isopropanol) and pH in a reaction medium; ii) reacting a physiologically active polypeptide with a non-peptidyl polymer (such as polyethylene glycol, polypropylene glycol, copolymers of ethylene glycol and propylene glycol, polyoxyethylated polyols, polyvinyl alcohol, polysaccharides, dextran, polyvinyl ethyl ether, PLA (poly(lactic acid)), PLGA (polylactic-glycolic acid), lipid polymers, chitins, hyaluronic acid, and combinations thereof) in a reaction medium having the kind and amount of an alcohol and the pH range determined in step i); and iii) isolating and purifying the physiologically active polypeptide conjugate from the reaction mixture of step (ii) by ion exchange chromatography using an alcohol.
Patent NZ-595985-A (NZ)
Title: A novel formulation of naproxen
Inventor: DODD AARON
IPC: A61K31/192
Filed: 2010-04-23
Abstract: The present invention relates to methods for producing particles of naproxen using dry milling processes as well as compositions comprising naproxen, medicaments produced using naproxen in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of naproxen administered by way of said medicaments.